As survival after orthotopic liver transplantation (OLT) improves, cardiovascular (CV) disease has emerged as the leading cause of non-graft-related deaths. The aims of our study were to determine the cumulative risk of CV events after OLT and to analyze predictive risk factors for those experiencin
Cumulative risk of cardiovascular events after orthotopic liver transplantation
โ Scribed by Mazen Albeldawi; Ashish Aggarwal; Surabhi Madhwal; Jacek Cywinski; Rocio Lopez; Bijan Eghtesad; Nizar N. Zein
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 825 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.22468
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Key Points 1. Yearly screening of liver recipients with serum cholesterol, triglycerides, and lipoproteins, and assessment for risk factors for atherosclerotic cardiovascular disease, is an important component of comprehensive post transplant care. 2. Revised guidelines and target levels of LDL-
A patient presented with intermittent high fever, upper abdominal pain, and loss of appetite 9 months after an orthotopic liver transplantation. Computed tomography showed a large mass in the pancreas that was confirmed at laparotomy. Pathological examination of the pancreatic biopsy specimen showed